Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
31,780
+552
+2% +$32.2K 0.01% 1033
2026
Q1
$1.7M Buy
31,228
+6,647
+27% +$383K 0.01% 989
2025
Q4
$1.66M Buy
24,581
+384
+2% +$27.8K 0.01% 951
2025
Q3
$1.88M Buy
24,197
+1,213
+5% +$108K 0.01% 783
2025
Q2
$2.35M Buy
22,984
+341
+2% +$37.6K 0.02% 604
2025
Q1
$2.52M Buy
22,643
+850
+4% +$94.9K 0.03% 460
2024
Q4
$2.41M Buy
21,793
+19,678
+930% +$2.2M 0.03% 435
2024
Q3
$230K Buy
+2,115
New +$211K ﹤0.01% 1240

Other funds holding CRVL

&Partners's CRVL Position: Q2 2026 in Review

&Partners increased its CorVel (CRVL) stake by 1.8% in Q2 2026, buying an estimated $32.2K and bringing the position to 31,780 shares worth $1.99M. The position accounts for 0.01% of the portfolio, ranked #1033.

&Partners first reported a position in CRVL in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.52M in Q1 2025. 290 funds tracked by Wall St. Rank hold CRVL as of Q2 2026.

  • &Partners held 31,780 shares of CorVel worth $1.99M as of Q2 2026.
  • &Partners bought 552 CorVel shares in Q2 2026, an estimated $32.2K.
  • CorVel made up 0.01% of &Partners's portfolio in Q2 2026, its #1033 holding.
  • &Partners first reported a position in CorVel in Q3 2024 and has held it in 8 quarters since.
  • &Partners's CorVel position peaked at $2.52M in Q1 2025.
  • 290 funds tracked by Wall St. Rank held CorVel as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.